Cash · 2012–2025

Novocure cash

$93.5M−42.9% · FY2025

Novocure (NVCR) reported $93.5M in cash for fiscal 2025, −42.9% year on year.

$34.9M2012$176M2013$57.6M2014$119M2015$99.8M2016$78.6M2017$141M2018$177M2019$235M2020$209M2021$115M2022$241M2023$164M2024$93.5M2025
Novocure — Cash, 2012–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$93.5M−42.9%Open →
FY20242024-12-31$164M−32.0%Open →
FY20232023-12-31$241M+108.8%Open →
FY20222022-12-31$115M−44.8%Open →
FY20212021-12-31$209M−11.0%Open →
FY20202020-12-31$235M+32.3%Open →
FY20192019-12-31$177M+26.1%Open →
FY20182018-12-31$141M+78.9%Open →
FY20172017-12-31$78.6M−21.2%Open →
FY20162016-12-31$99.8M−16.4%Open →
FY20152015-12-31$119M+107.3%Open →
FY20142014-12-31$57.6M−67.2%Open →
FY20132013-12-31$176M+404.1%Open →
FY20122012-12-31$34.9M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2012–2025 compound annual growth +7.9%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Novocure cash |url=https://companiesranked.com/en/company/novocure/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Novocure cash. CompaniesRanked. https://companiesranked.com/en/company/novocure/cash-on-hand

BibTeX

@misc{companiesranked-en-company-novocure-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Novocure cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/novocure/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001645113-26-000062 · July 23, 2026

{{cite web |title=Novocure cash — 10-Q (0001645113-26-000062) |url=https://www.sec.gov/Archives/edgar/data/1645113/000164511326000062/nvcr-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-23}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Novocure overview